MedTrace Logo

Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer

NCT00393341 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 68

Last updated 2015-08-31

No results posted yet for this study

Summary

We propose to quantitate endothelial progenitor cells (EPCs) in early and advanced breast cancer patients. Peripheral blood will be drawn from the eligible patients. Different type of EPCs will be isolated from the blood and quantitated.

Conditions

  • Breast Cancer Stage IV
  • Breast Cancer Stage I
  • Breast Cancer Stage II

Interventions

PROCEDURE

Blood Draw

Blood sample will be drawn from a vein in the arm.

Sponsors & Collaborators

  • Breast Cancer Research Foundation

    collaborator OTHER

  • Indiana University School of Medicine

    lead OTHER

Principal Investigators

  • George W Sledge, MD · Indiana University

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2009-05-31
Completion
2009-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00393341 on ClinicalTrials.gov